Paradoxical activation of alternative pro-survival pathways determines resistance to MEK inhibitors in chronic lymphocytic leukaemia.
Yixiang ChenSandra GermanoGhalia ShelmaniDiana KlucznaSandrine JayneMartin J S DyerSalvador MacipPublished in: British journal of haematology (2017)